COMMUNIQUÉS West-GlobeNewswire

Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance
04/05/2026
ANNOUNCEMENT NO. 307 4 May 2026 Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance To ensure continued compliance with the applicable accounting framework (IFRS), [...]
Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation
04/05/2026
Oslo, Norway, 4 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of [...]
Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026
04/05/2026
REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. [...]
CDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results
04/05/2026
Tarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) -- The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification Certification reaffirms assay results are aligned with specialized mass [...]
Xpress Wellness Acquires Wichita’s Mental Health Clinic Midwest Counseling Services
04/05/2026
Acquisition furthers Xpress Wellness’ future growth in behavioral health in Kansas and Adjacent State Key facts of this press release: Xpress Wellness acquired Wichita’s Midwest Counseling Services on April 1, 2026 [...]
Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
04/05/2026
HALIFAX, Nova Scotia, May 04, 2026 (GLOBE NEWSWIRE) -- To mark World Ovarian Cancer Day, Ovarian Cancer Canada is announcing a $725,000 investment to fuel critical ovarian cancer research. Led by globally respected [...]
Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps
04/05/2026
Seasonal pollen doesn't just trigger sneezing. It compounds respiratory stress in ways most allergy sufferers don't expect. Austin, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Spring Allergies Hit Lungs Hard — Pharmacist [...]
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
04/05/2026
FDA-IDE approved study enrolls first patient for robotic-assisted surgical intervention for neurodegenerative disease JACKSONVILLE, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics [...]
ApolloMD Surpasses $1.5 Billion in Patient Debt Relief Through Ongoing Partnership with Cascade365, Coordinated by Undue Medical Debt
04/05/2026
ATLANTA, May 04, 2026 (GLOBE NEWSWIRE) -- ApolloMD has helped eliminate more than $1.5 billion in patient medical debt since 2018, marking a significant milestone in its ongoing partnership with Cascade365 and its [...]
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel
04/05/2026
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals FORT MILL, SC, May 04, 2026 (GLOBE NEWSWIRE) -- — Flyte, the regional air [...]
TimelyCare Acquires Alongside to Expand Continuous Student Support with Clinician-Powered AI Coaching
04/05/2026
Acquisition adds an early-intervention and engagement layer to TimelyCare’s education-first care continuum while preserving continuity for existing partners. Fort Worth, TX, May 04, 2026 (GLOBE NEWSWIRE) -- May 4, 2026 [...]
Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation (corrected time)
04/05/2026
Oslo, Norway, 4 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of [...]
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
04/05/2026
Clinically significant angiokeratomas represent a rare, chronic and debilitating lymphatic malformation with no FDA-approved therapies and an estimated more than 50,000 diagnosed patients in the U.S. Phase 2 single-arm [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
04/05/2026
PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced [...]
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
04/05/2026
• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the potential to receive an additional near-term sales-based milestone of up to $20 million ROCKVILLE, MD, May 04, 2026 ( [...]
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and [...]
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
04/05/2026
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, [...]
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
04/05/2026
Oral presentation includes early readouts from preclinical testing of CAR-encoding episomal DNA delivered by targeted lipid nanoparticles CPTx will present two posters at ASGCT 2026 Munich, Germany — May 4, 2026 — CPTx [...]

Pages